Beat Foerster

MD, Urologist, Department of Urology, Kantonsspital Winterthur, Switzerland

[Carissa Chu @CChuMD]

New 2023 SUO/AUA guidelines for UTUC: https://t.co/qNN1corEsV

🔬Universal histologic assessment
👨‍👩‍👧‍👦Screening for Lynch syndrome
🚦New risk stratification
💊NAC for high risk disease
🗓️Helpful surveillance table

Led by Dr Coleman @UrologyMSK and many others 👏🏼

[splernerMD @slernerbcmedu1]

@SWOG @BladderCancerUS @bcmhouston @SvatekRob @montypal @neerajaiims @siadaneshmand @bcm_urology @NCICTEP_ClinRes @BladderCaJrnl @JoshMeeks @UroDocAsh Thanks for the incredible support from SWOG and my colleagues across the NCTN. We started this project in 2010. 5 and a half years of accrual and 6 of follow-up. Worth all of it to answer this important surgical question

[Christoph Schregel @chschrek]

Which tools do you use for detecting AI-generated text fragments in scientific publications?
I currently use https://t.co/ER74kn6BqM and zerogpt https://t.co/j9F6DHNjWs.

@uroGPT @Cacciamani_MD @EAU_YAUroTech

[European Urology @EUplatinum]

Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study
https://t.co/Pkhpjrx3xU
@beatfoerster @DrShariat @MAbufaraj @drphil_urology @SurenaMatinMD @frasor86 @MounsifAzizi @joniau

[European Urology @EUplatinum]

January 2021 Issue

Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials
https://t.co/LUX2DdzM3Z
#VisualAbstract

[Urologic Oncology Research MedUni Vienna @Uro_MedUniWien]

#Originalarticle
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract #UrothelialCarcinoma
@beatfoerster @DrShariat @MedUni_Wien
@UrowebESU @Uroweb
https://t.co/0s3uFvlaXZ

[European Urology @EUplatinum]

September 2020 Surgery in Motion
Best Practices in Robotic-assisted Repair of Vesicovaginal Fistula: A Consensus Report from the European Association of Urology Robotic Urology Section Scientific Working Group for Reconstructive Urology https://t.co/y8SbpeAtF7

[European Urology @EUplatinum]

New Surgery in Motion
Best Practices in Robotic-assisted Repair of Vesicovaginal Fistula: A Consensus Report from the European Association of Urology Robotic Urology Section Scientific Working Group for Reconstructive Urology
@alexmottrie @Aploumidis1
https://t.co/y8SbpeAtF7

[European Urology @EUplatinum]

Differential Impact of GnRH Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic PCa: A Meta-analysis of Randomized Controlled Trials
#VisualAbstract
@MAbufaraj @DrShariat @AnoudHaddad @UroMoschini
https://t.co/LUX2DdzM3Z

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

On heels of #ASCO20, gentle reminder of context of FDA Guidance for BCG Unresponsive Disease (not BCG refractory, not relapsing, ...)

Our workshop at #EAU2020 with @MarekBabjuk @joanfundi @DrShariat

@IBCG_BladderCA: https://t.co/agHDM6kzge
@FDAOncology: https://t.co/oxPEvsVH9W

[Toni Choueiri, MD @DrChoueiri]

Excellent take on cytoreductive nephrectomy from @ShaanDudani @DrDanielHeng #IMDC @ASCOPost @ASCO @ASCO_pubs

[Farbod Saraf @farbodsaraf]

A punt return for the ages

[Marco Moschini @UroMoschini]

I was preparing a presentation and found out that the consensus for molecular classification in bladder cancer article @EUplatinum has been temoporary removed.
Does anybody know the reason?
https://t.co/Fnx3GYF5p0

[Andrea Necchi, MD, FASCO @AndreaNecchi]

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma https://t.co/QKLlpMpAyt

[Beat Foerster @beatfoerster]

@UroMoschini thanks marco, fantastic to see you here in zurich at the swiss annual meeting!

[Shahrokh F. Shariat @DrShariat]

Molecular dissection of UTUC: 1) most are luminal-papillary; 2) has a T-cell depleted immune contexture; 3) high FGFR3 expression enrichment; 4) sporadic UTUC characterized by lower total mutational burden than bladder cancer. https://t.co/oUZOAKFulz

[JAMA Oncology @JAMAOnc]

https://t.co/MLUGUWhnVx

[European Urology @EUplatinum]

Patients treated with EBRT are at increased risk of developing a second primary BCa compared to those treated with RP https://t.co/sCbB3CNlwi

[David D'Andrea @DavDandrea]

Every researcher should read this comment! It’s imperative to discern “clinically significant” from “statistically significant” https://t.co/OjcEMN70xX

[Marco Moschini @UroMoschini]

@MAbufaraj reporting results of impact of hormones on #bladdercancer . #EAU19